Windsor Capital Management’s NanoViricides NNVC Stock Holding History

Windsor Capital Management’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-86	Closed	-$2K	–	312
2015 Q3	$2K	Buy	+86	New	+$2.28K	﹤0.01%	511

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SIP

Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Windsor Capital Management's NNVC Position: Q4 2015 in Review

Windsor Capital Management sold out of NanoViricides (NNVC) in Q4 2015, closing a stake of 86 shares — an estimated $2K sold.

Windsor Capital Management first reported a position in NNVC in Q3 2015 and held it in 1 quarter. The position peaked at $2K in Q3 2015. 41 funds tracked by Wall St. Rank hold NNVC as of Q4 2015.

Windsor Capital Management reported no remaining NanoViricides position as of Q4 2015 after selling out during the quarter.
Windsor Capital Management sold 86 NanoViricides shares in Q4 2015, an estimated $2K.
Windsor Capital Management first reported a position in NanoViricides in Q3 2015 and held it in 1 quarter.
Windsor Capital Management's NanoViricides position peaked at $2K in Q3 2015.
41 funds tracked by Wall St. Rank held NanoViricides as of Q4 2015.

Based on Windsor Capital Management's 13F filing for Q4 2015, filed 1 Feb 2016.